Luis Mario Rodríguez-Martínez

Dr. Luis Mario Rodríguez-Martínez


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
LRLuis Mario Rodríguez-Martínez
Luis Mario Rodríguez-Martínez
JCJose Luis Chavelas-Reyes
Jose Luis Chavelas-Reyes
CRCarlo Franco Medina Ramirez
Carlo Franco Medina Ramirez
ECEli de Jesús Fuentes Chávez
Eli de Jesús Fuentes Chávez
ZMZurisaday Sheccid Muñoz
Zurisaday Sheccid Muñoz
JRJosefina G. Rodríguez-González
Josefina G. Rodríguez-González
Tuberculosis (TB), caused by Mycobacterium tuberculosis, continues to be a leading cause of morbidity and mortality in Mexico, with more than 20,000 new cases annually and a rising proportion of drug-resistant strains. This work addresses the molecular epidemiology of TB in the Mexican context, emphasizing its role in understanding transmission, genetic diversity, and resistance mechanisms. To achieve this, we reviewed molecular typing approaches including spoligotyping, Mycobacterial Interspersed Repetitive Unit–Variable Number Tandem Repeat (MIRU-VNTR) analysis, and whole-genome sequencing (WGS), which have been applied to characterize circulating lineages and identify drug-resistance-associated mutations. The results indicate that the Euro-American lineage (L4) predominates across the country, although significant regional variation exists, with Haarlem, LAM, T, and X sub lineages dominating in different states, and occasional detection of Asian (L2) and Indo-Oceanic (L1) lineages. Key resistance mutations were identified in katG, rpoB, pncA, and gyrA, contributing to the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains, particularly in border and marginalized regions. These findings highlight how social factors, such as migration, urban overcrowding, and comorbidities including diabetes and HIV, influence transmission dynamics. We conclude that integrating molecular tools with epidemiological surveillance is crucial for strengthening public health strategies and guiding interventions tailored to Mexico’s heterogeneous TB burden.

11 March 2026 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
LRLuis Mario Rodríguez-Martínez
Luis Mario Rodríguez-Martínez
JCJose Luis Chavelas-Reyes
Jose Luis Chavelas-Reyes
CRCarlo Franco Medina Ramirez
Carlo Franco Medina Ramirez
JVJorge A. Valdés-González
Jorge A. Valdés-González
ECEli de Jesús Fuentes Chávez
Eli de Jesús Fuentes Chávez
JRJosefina G. Rodríguez-González
Josefina G. Rodríguez-González
Bovine tuberculosis (bTB), caused by Mycobacterium bovis, remains one of the most relevant zoonotic diseases worldwide due to its dual impact on livestock production and human health. Although zoonotic tuberculosis has been virtually eradicated from cattle in a few settings, particularly in Australia, the disease persists in much of Latin America, Africa, and Asia, where it continues to limit cattle productivity and pose a threat to public health through the consumption of unpasteurized dairy products and occupational exposure. This review integrates historical, epidemiological, clinical, and molecular perspectives of bTB, with particular emphasis on Mexico, highlighting the role of wildlife reservoirs, socioeconomic factors, and diagnostic limitations in maintaining endemicity. Recent advances in molecular epidemiology, such as PCR, MIRU-VNTR, and whole-genome sequencing, provide promising avenues for surveillance and control. Finally, we discuss the importance of adopting a One Health framework that bridges veterinary, medical, and environmental approaches to achieve sustainable control of this silent zoonosis.

Verified
Journal Article
Open access
PDF file
CRCarlo Franco Medina Ramirez
Carlo Franco Medina Ramirez
JCJose L. Chavelas-Reyes
Jose L. Chavelas-Reyes
JRJosefina G. Rodríguez-González
Josefina G. Rodríguez-González
NFNadia A. Fernández-Santos
Nadia A. Fernández-Santos
LWLihua Wei
Lihua Wei
MRMario A. Rodríguez-Pérez
Mario A. Rodríguez-Pérez
Understanding the molecular mechanisms underlying host immune responses to SARS-CoV-2 vaccination remains essential, particularly in populations with a high prevalence of obesity. In this cross-sectional study, we evaluated whether body mass index (BMI) is associated with vaccine-induced humoral immunity in a cohort from northeastern Mexico and discuss the findings within a structural immunology framework of spike antigenicity and antibody–epitope interactions. A total of 138 adults were recruited in Reynosa and Matamoros (June 2021–June 2022) and categorized as healthy weight, overweight, or obese according to BMI criteria. Serum anti-SARS-CoV-2 IgG was assessed using an ELISA-based assay, and differences across BMI groups were tested using the Kruskal–Wallis approach. Among all participants, 33.3% were classified as obese and 99.3% (137/138) were seropositive for anti-SARS-CoV-2 IgG. No significant differences in IgG levels were detected between BMI categories (p = 0.20). These results indicate that, in this Mexican cohort—sampled during a period of heterogeneous and often incomplete vaccination schedules—obesity was not associated with reduced detectable anti-SARS-CoV-2 IgG responses. Our findings support the need to integrate population-level serology with mechanistic studies that interrogate antibody quality (e.g., neutralization potency and epitope specificity) to better connect clinical determinants such as obesity with molecular correlates of protection.